Chikungunya outbreak (2015) in the Colombian Caribbean: Latent classes and gender differences in virus infection.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
06 2020
Historique:
received: 30 09 2019
accepted: 08 04 2020
revised: 19 06 2020
pubmed: 4 6 2020
medline: 11 8 2020
entrez: 4 6 2020
Statut: epublish

Résumé

Chikungunya virus (CHIKV), a mosquito-borne alphavirus of the Togaviridae family, is part of a group of emergent diseases, including arbovirus, constituting an increasing public health problem in tropical areas worldwide. CHIKV causes a severe and debilitating disease with high morbidity. The first Colombian autochthonous case was reported in the Colombian Caribbean region in September 2014. Within the next two to three months, the CHIKV outbreak reached its peak. Although the CHIKV pattern of clinical symptomatology has been documented in different epidemiological studies, understanding of the relationship between clinical symptomatology and variation in phenotypic response to CHIKV infection in humans remains limited. We performed a cross sectional study following 1160 individuals clinically diagnosed with CHIKV at the peak of the Chikungunya outbreak in the Colombian Caribbean region. We examined the relationship between symptomatology and diverse phenotypic responses. Latent Class Cluster Analysis (LCCA) models were used to characterize patients' symptomatology and further identify subgroups of individuals with differential phenotypic response. We found that most individuals presented fever (94.4%), headache (73.28%) and general discomfort (59.4%), which are distinct clinical symptoms of a viral infection. Furthermore, 11/26 (43.2%) of the categorized symptoms were more frequent in women than in men. LCCA disclosed seven distinctive phenotypic response profiles in this population of CHIKV infected individuals. Interestingly, 282 (24.3%) individuals exhibited a lower symptomatic "extreme" phenotype and 74 (6.4%) patients were within the severe complex "extreme" phenotype. Although clinical symptomatology may be diverse, there are distinct symptoms or group of symptoms that can be correlated with differential phenotypic response and perhaps susceptibility to CHIKV infection, especially in the female population. This suggests that, comparatively to men, women are a CHIKV at-risk population. Further study is needed to validate these results and determine whether the distinct LCCA profiles are a result of the immune response or a mixture of genetic, lifestyle and environmental factors. Our findings could contribute to the development of machine learning approaches to characterizing CHIKV infection in other populations. Preliminary results have shown prediction models achieving up to 92% accuracy overall, with substantial sensitivity, specificity and accuracy values per LCCA-derived cluster.

Identifiants

pubmed: 32492017
doi: 10.1371/journal.pntd.0008281
pii: PNTD-D-19-01462
pmc: PMC7304630
doi:

Substances chimiques

RNA, Viral 0

Banques de données

figshare
['10.6084/m9.figshare.12478004']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0008281

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Immunol. 2017 Mar 1;198(5):1782-1790
pubmed: 28223406
J Clin Virol. 2019 Apr;113:27-30
pubmed: 30836281
J Atten Disord. 2018 Mar 1;:1087054718763741
pubmed: 29589797
PLoS Negl Trop Dis. 2015 May 07;9(5):e0003764
pubmed: 25951202
J Immunol. 2010 May 15;184(10):5903-13
pubmed: 20404274
PLoS Pathog. 2019 Nov 11;15(11):e1008089
pubmed: 31710653
Microorganisms. 2019 May 14;7(5):
pubmed: 31091828
Pharmacol Ther. 2005 Sep;107(3):329-42
pubmed: 15923040
Clin Exp Immunol. 2007 Aug;149(2):217-25
pubmed: 17590166
Trends Microbiol. 2017 Nov;25(11):875-876
pubmed: 28969882
Am J Trop Med Hyg. 2016 Apr;94(4):800-3
pubmed: 26856917
Clin Infect Dis. 2007 Jun 1;44(11):1401-7
pubmed: 17479933
Front Cell Infect Microbiol. 2018 Oct 10;8:345
pubmed: 30364124
Epidemiol Infect. 2012 May;140(5):842-50
pubmed: 21767452
Ann N Y Acad Sci. 2007 Apr;1102:96-108
pubmed: 17470914
Med J Aust. 1996 Jan 15;164(2):90-3
pubmed: 8569580
J Infect Dis. 2014 Jul 15;209 Suppl 3:S79-80
pubmed: 24966193
Viral Immunol. 2017 Dec;30(10):691-702
pubmed: 28910194
Arch Public Health. 2017 Jan 6;75:1
pubmed: 28074128
Virology. 2017 Nov;511:207-213
pubmed: 28888110
Am J Trop Med Hyg. 1981 Sep;30(5):1053-9
pubmed: 7283004
Antiviral Res. 2015 Aug;120:32-9
pubmed: 25979669
Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1023-1034
pubmed: 30771124
Viruses. 2017 Dec 01;9(12):
pubmed: 29194359
Bioessays. 2012 Dec;34(12):1050-9
pubmed: 23012250
Trans R Soc Trop Med Hyg. 2015 Jan;109(1):9-15
pubmed: 25573105
Epidemiol Infect. 2009 Apr;137(4):534-41
pubmed: 18694529
Lancet Infect Dis. 2007 May;7(5):319-27
pubmed: 17448935
Cells. 2019 Aug 16;8(8):
pubmed: 31426340
Clin Infect Dis. 2009 Sep 15;49(6):942-8
pubmed: 19663604
Viruses. 2019 Feb 12;11(2):
pubmed: 30759739
Int J Environ Res Public Health. 2018 Jul 27;15(8):
pubmed: 30060525
Clin Microbiol Rev. 2001 Oct;14(4):909-32, table of contents
pubmed: 11585790
Curr Opin Infect Dis. 2016 Oct;29(5):467-75
pubmed: 27472289
PLoS One. 2012;7(6):e39853
pubmed: 22768144
J Infect Dis. 2016 Dec 15;214(suppl 5):S441-S445
pubmed: 27920170
J Immunol. 2006 Aug 15;177(4):2088-96
pubmed: 16887967
Influenza Other Respir Viruses. 2011 Sep;5(5):334-42
pubmed: 21668688
Autoimmunity. 2005 May;38(3):235-45
pubmed: 16126512
Immunol Res. 2006;34(3):177-92
pubmed: 16891670
PLoS Negl Trop Dis. 2012;6(3):e1446
pubmed: 22479654
Virology. 2009 Oct 25;393(2):183-97
pubmed: 19732931
Antiviral Res. 2013 Sep;99(3):345-70
pubmed: 23811281
Ann Clin Microbiol Antimicrob. 2016 Jul 22;15(1):42
pubmed: 27449770
PLoS One. 2012;7(2):e30025
pubmed: 22363413
Microbes Infect. 2009 Dec;11(14-15):1186-96
pubmed: 19737625

Auteurs

Oscar M Vidal (OM)

Universidad del Norte, Barranquilla, Colombia.

Jorge Acosta-Reyes (J)

Universidad del Norte, Barranquilla, Colombia.

Jesús Padilla (J)

Universidad del Norte, Barranquilla, Colombia.

Edgar Navarro-Lechuga (E)

Universidad del Norte, Barranquilla, Colombia.

Elsa Bravo (E)

Epidemiological Surveillance Team, Health Secretary Program, Barranquilla, Colombia.

Diego Viasus (D)

Universidad del Norte, Barranquilla, Colombia.

Mauricio Arcos-Burgos (M)

Grupo de Investigación en Psiquiatría (GIPSI), Departamento de Psiquiatría, Instituto de Investigaciones Médicas, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.

Jorge I Vélez (JI)

Universidad del Norte, Barranquilla, Colombia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH